PD-2244

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NamePD-2244
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-10 modulatorsTumor necrosis factor α inhibitors
TargetsInterleukin-10Tumor necrosis factor α
Therapy Area/IndicationsAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesP2d, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesP2d, Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseDementia

Other Information

ATC CodeN/A
Related LinksN/A